| Identification | Back Directory | [Name]
N-[2-[5-(Aminoiminomethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-methylglycine | [CAS]
183305-24-0 | [Synonyms]
CI 1031
BX807834
BX-807834
PD-200022
ZK 807834
Fidexaban
N-[2-[5-(Aminoiminomethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-methylglycine
Glycine, N-[2-[5-(aMinoiMinoMethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-Methyl-1H-iMidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-Methyl- | [Molecular Formula]
C25H24F2N6O5 | [MDL Number]
MFCD18251497 | [MOL File]
183305-24-0.mol | [Molecular Weight]
526.49 |
| Hazard Information | Back Directory | [Uses]
Fidexaban is a Factor Xa inhibitor and can be used in research of cardiovascular disease[1]. | [References]
[1] Remko M, et al. Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors. Molecules. 2016 Feb 4;21(2):185. DOI:10.3390/molecules21020185 |
|
|